iShares Biotechnology ETF | IBBRegístrese para Ver el Rating |
Cómo se ha comportado este fondo | 31/05/2024 |
Crecimiento de 1.000 (EUR) | Gráfico Avanzado |
Fondo | 15,6 | 8,6 | -8,0 | 0,2 | 0,4 | |
+/-Cat | -1,5 | -6,4 | 1,6 | 0,5 | -3,4 | |
+/-Ind | 9,0 | -18,9 | 5,0 | -17,8 | -10,4 | |
Categoría: Health | ||||||
Benchmark de la Categoría: MSCI ACWI NR USD |
Estadística Rápida | ||
Precio de Cierre 13/06/2024 | USD 137,33 | |
Cambio del día | 0,36% | |
Categoría Morningstar™ | Health | |
Volumen | 1710441 | |
Bolsa | NASDAQ | |
ISIN | US4642875565 | |
Patrimonio (Mil) - | - | |
Patrimonio Clase (Mil) 12/06/2024 | USD 7420,36 | |
Gastos Corrientes - | -% |
Morningstar Research |
Objetivo de inversión: iShares Biotechnology ETF | IBB |
The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified. |
Returns | |||||||||||||
|
Gestión | ||
Nombre del gestor Fecha Inicio | ||
Greg Savage 01/01/2008 | ||
Jennifer Hsui 01/08/2012 | ||
Click here to see others | ||
Creación del fondo 05/02/2001 |
Anuncio publicitario |
Benchmark de la Categoría | |
Benchmark de fondos | Benchmark Morningstar |
NYSE Biotechnology TR USD | MSCI ACWI NR USD |
Target Market | ||||||||||||||||||||
|
Qué posee el fondo iShares Biotechnology ETF | IBB | 10/06/2024 |
|
|
5 mayores posic. | Sector | % |
Vertex Pharmaceuticals Inc | Salud | 9,30 |
Amgen Inc | Salud | 9,01 |
Regeneron Pharmaceuticals Inc | Salud | 8,40 |
Gilead Sciences Inc | Salud | 7,33 |
Moderna Inc | Salud | 4,91 |
Incremento Reducción Nuevo desde la anterior cartera | ||
iShares Biotechnology ETF | IBB |